Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease

Arch Pharm (Weinheim). 2020 Oct;353(10):e2000101. doi: 10.1002/ardp.202000101. Epub 2020 Jul 13.

Abstract

In search of safer tacrine analogs, various thieno[2,3-b]pyridine amine derivatives were synthesized and evaluated for their inhibitory activity against cholinesterases (ChEs). Among the synthesized compounds, compounds 5e and 5d showed the highest activity towards acetylcholinesterase and butyrylcholinesterase, with IC50 values of 1.55 and 0.23 µM, respectively. The most active ChE inhibitors (5e and 5d) were also candidates for further complementary assays, such as kinetic and molecular docking studies as well as studies on inhibitory activity towards amyloid-beta (βA) aggregation and β-secretase 1, neuroprotectivity, and cytotoxicity against HepG2 cells. Our results indicated efficient anti-Alzheimer's activity of the synthesized compounds.

Keywords: Alzheimer's disease; BACE1; amyloid beta (βA); cytotoxicity; thieno[2,3-b]pyridine.

MeSH terms

  • Acetylcholinesterase / drug effects
  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy
  • Amines / chemical synthesis
  • Amines / chemistry
  • Amines / pharmacology
  • Butyrylcholinesterase / drug effects
  • Butyrylcholinesterase / metabolism
  • Cholinesterase Inhibitors / chemical synthesis
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Hep G2 Cells
  • Humans
  • Inhibitory Concentration 50
  • Molecular Docking Simulation
  • Pyridines / chemical synthesis
  • Pyridines / chemistry
  • Pyridines / pharmacology*
  • Tacrine / chemical synthesis
  • Tacrine / chemistry
  • Tacrine / pharmacology*

Substances

  • Amines
  • Cholinesterase Inhibitors
  • Pyridines
  • thieno(2,3-b)pyridine
  • Tacrine
  • Acetylcholinesterase
  • Butyrylcholinesterase